Role of PET/CT in improving the cost effectiveness of nimotuzumab in nasopharyngeal carcinoma
Saved in:
| Main Authors: | Xiao-bin Fu, Ting-ting Li, Zhao-dong Fei, Chuan-ben Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pacini Editore Srl
2024-10-01
|
| Series: | Acta Otorhinolaryngologica Italica |
| Online Access: | https://www.actaitalica.it/article/view/766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress of Nimotuzumab Application in Nasopharyngeal Carcinoma
by: Tianci LIANG, et al.
Published: (2024-11-01) -
Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study
by: Mingfen Lai, et al.
Published: (2025-06-01) -
Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial
by: Qihua Zou, et al.
Published: (2025-05-01) -
Prognostic value of primary gross tumor volume and standardized uptake value of F-FDG in PET/CT for distant metastasis in locoregionally advanced nasopharyngeal carcinoma
by: Ya-Nan Jin, et al.
Published: (2017-06-01) -
Radiologic Predictors of Disease Recurrence in Nasopharyngeal Carcinoma: A Retrospective Evaluation of MRI and <sup>18</sup>F-FDG-PET/CT Parameters
by: Banu Karaalioğlu, et al.
Published: (2025-06-01)